[The effects of combined chemotherapy (adriamycin/VM/26/CCNU) in brian tumours in adults and animal experiments (author's transl)].
D000328:Adult; D000368:Aged; D000818:Animals; D001932:Brain Neoplasms / Q000139:chemically induced / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005038:Ethylnitrosourea; D005260:Female; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D007427:Intracranial Pressure; D008130:Lomustine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D011034:Podophyllotoxin / Q000627:therapeutic use*; D051381:Rats; D013534:Survival
D009607:Nitrosourea Compounds; D008130:Lomustine; D004317:Doxorubicin; D011034:Podophyllotoxin; D005038:Ethylnitrosourea
Die Wirkung kombinierter Chemotherapie (Adriamycin/VM 26/CCNU) bei hirneigenen Tumoren des Erwachsenenalters und im Tierexperiment.